Tenax Therapeutics maintains LEVEL study enrollment target after review Dec 17, 2025 09:17AM
Tenax Therapeutics (TENX) PT Raised to $25 at Guggenheim Dec 17, 2025 06:46AM
Tenax Therapeutics (TENX) Misses Q3 EPS by 40c Nov 13, 2025 06:29AM
Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work' Oct 1, 2025 01:20PM
FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment' Oct 1, 2025 01:13PM


Sep 16, 2025 07:00AM Tenax Therapeutics receives European patent intention for levosimendan
Sep 8, 2025 03:49AM Piper Sandler Starts Tenax Therapeutics (TENX) at Overweight
Aug 14, 2025 06:57AM Tenax Therapeutics (TENX) PT Lowered to $14 at Guggenheim
Aug 13, 2025 06:21PM Tenax Therapeutics (TENX) Misses Q2 EPS by 27c
May 14, 2025 06:32PM Tenax Therapeutics (TENX) Misses Q1 EPS by 28c
Mar 25, 2025 05:03PM Tenax Therapeutics (TENX) Misses Q4 EPS by 18c
Mar 10, 2025 06:22AM Tenax Therapeutics (TENX) PT Raised to $20 at Leerink Partners
Mar 5, 2025 08:48AM Tenax Therapeutics (TENX) announces private placement of $25 million
Mar 5, 2025 08:43AM Tenax Therapeutics (TENX) Expands Phase 3 LEVEL Program
Feb 5, 2025 06:30AM This stock offers 'tremendous optionality in 2H25': analyst
Jan 22, 2025 08:02AM Tenax Therapeutics (TENX) Appoints Gillian Andor Vice President, Clinical Operations
Nov 13, 2024 04:16PM Tenax Therapeutics (TENX) Misses Q3 EPS by 19c
Oct 24, 2024 06:29AM Leerink Partners Starts Tenax Therapeutics (TENX) at Outperform
Aug 13, 2024 06:11PM Tenax Therapeutics (TENX) Misses Q2 EPS by 183c
Aug 12, 2024 08:07AM Tenax Therapeutics (TENX) Announces Closing of $100 Million Private Placement and Plans to Accelerate the Oral Levosimendan Phase 3 Program
Aug 6, 2024 07:13AM Tenax Therapeutics (TENX) Announces $100M Private Placement